As of 2025-09-16, the Relative Valuation of C4 Therapeutics Inc (CCCC) is (57.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.57 USD, the upside of C4 Therapeutics Inc based on Relative Valuation is -1697.3%.
The range of the Relative Valuation is (55.89) - (59.30) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.1x - 28.2x | 24.4x |
| Forward P/E multiples | 26.6x - 32.1x | 29.8x |
| Fair Price | (55.89) - (59.30) | (57.02) |
| Upside | -1665.5% - -1760.9% | -1697.3% |
| Date | P/E |
| 2025-09-12 | -1.26 |
| 2025-09-11 | -1.30 |
| 2025-09-10 | -1.25 |
| 2025-09-09 | -1.27 |
| 2025-09-08 | -1.29 |
| 2025-09-05 | -1.29 |
| 2025-09-04 | -1.27 |
| 2025-09-03 | -1.22 |
| 2025-09-02 | -1.19 |
| 2025-08-29 | -1.24 |
| 2025-08-28 | -1.21 |
| 2025-08-27 | -1.23 |
| 2025-08-26 | -1.22 |
| 2025-08-25 | -1.20 |
| 2025-08-22 | -1.24 |
| 2025-08-21 | -1.24 |
| 2025-08-20 | -1.24 |
| 2025-08-19 | -1.31 |
| 2025-08-18 | -1.36 |
| 2025-08-15 | -1.17 |
| 2025-08-14 | -1.12 |
| 2025-08-13 | -1.11 |
| 2025-08-12 | -1.06 |
| 2025-08-11 | -1.15 |
| 2025-08-08 | -1.19 |
| 2025-08-07 | -1.23 |
| 2025-08-06 | -0.93 |
| 2025-08-05 | -0.96 |
| 2025-08-04 | -1.00 |
| 2025-08-01 | -1.01 |
| 2025-07-31 | -0.97 |
| 2025-07-30 | -1.03 |
| 2025-07-29 | -1.07 |
| 2025-07-28 | -1.04 |
| 2025-07-25 | -1.07 |
| 2025-07-24 | -1.09 |
| 2025-07-23 | -1.15 |
| 2025-07-22 | -1.06 |
| 2025-07-21 | -1.08 |
| 2025-07-18 | -1.10 |
| 2025-07-17 | -1.04 |
| 2025-07-16 | -0.96 |
| 2025-07-15 | -1.00 |
| 2025-07-14 | -1.13 |
| 2025-07-11 | -1.06 |
| 2025-07-10 | -0.95 |
| 2025-07-09 | -0.96 |
| 2025-07-08 | -0.81 |
| 2025-07-07 | -0.72 |
| 2025-07-03 | -0.70 |